My Own Med, Inc.
Chevy Chase, MD Doing business as Respondhealth
- UEI
- YJNCFMF1W9A6
- CAGE
- 808L1
- Primary NAICS
- 541511 Custom Computer Programming Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4825 Essex Ave, Chevy Chase, MD 20815, USA
- Website
- respond.health
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir 136 - my own MED | National Institute of Allergy and Infectious Diseases | $275,942 |
About My Own Med, Inc.
My Own Med, Inc., doing business as Respondhealth, is a woman-owned small business registered in the System for Award Management (SAM) since October 2017, with its registration valid until January 2026. The company specializes in developing digital health platforms, specifically the M2Study Platform, which includes a mobile application and web portal for medical research and symptom tracking. Their primary focus appears to be providing Software as a Service (SaaS) solutions for medical research, with particular emphasis on digital health monitoring and data analytics.
The company has received a significant federal contract from the National Institute of Allergy and Infectious Diseases (NIAID) valued at $275,942. This Firm Fixed Price contract, awarded on September 5, 2024, is for the SBIR 136 - MY OWN MED project and does not have a specific set-aside designation. The contract involves providing the M2Study Platform, which includes a mobile app with a COVID-19 symptom tracker and a portal for database analytics. The contract is scheduled for completion on September 4, 2025, and represents the company's engagement with a civilian federal agency in developing innovative digital health research tools.
My Own Med, Inc. has been extensively involved in federal grant work, primarily through sub-awards from Benaroya Research Institute At Virginia Mason. These grant awards, dating from October 2021 to December 2024, consistently involve providing the M2Study Platform for medical research purposes. The grant work has focused on supporting research initiatives, particularly those related to COVID-19 symptom tracking and medical data analytics. The sub-awards typically specify a study duration of 41 months, involving 15-20 research sites and approximately 104 participants. These grants demonstrate the company's capability to provide specialized digital health research platforms that support comprehensive medical studies across multiple research sites.
SBA capabilities narrative
A Life Sciences Innovation Company that Builds Digitally Powered Real World Evidence. We are a team of experts with over 20 years of experience in science, clinical trials, health care policy, and medical product regulation. Our regulatory, policy and science expertise is used to drive development of technology solutions that capture critical elements of the patient's healthcare experience (real world evidence) to drive smarter healthcare interventions and products.
Quick answers
What is My Own Med, Inc.'s UEI?
My Own Med, Inc.'s Unique Entity ID (UEI) in SAM.gov is YJNCFMF1W9A6.
What is My Own Med, Inc.'s CAGE code?
My Own Med, Inc.'s CAGE code is 808L1.
What is My Own Med, Inc.'s primary NAICS code?
My Own Med, Inc.'s primary NAICS code is 541511 (Custom Computer Programming Services).
Where is My Own Med, Inc. located?
My Own Med, Inc.'s physical address in SAM.gov is 4825 Essex Ave, Chevy Chase, MD 20815, USA.
Is My Own Med, Inc. registered in SAM.gov?
Yes. My Own Med, Inc.'s SAM.gov registration is active through August 26, 2027.
What is My Own Med, Inc.'s most recent federal award?
My Own Med, Inc.'s most recent federal contract award is Sbir 136 - my own MED (75N93024C00036), from National Institute of Allergy and Infectious Diseases, on September 5, 2024.
On GovTribe
See My Own Med, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors